Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Cardiovascular Considerations of Remdesivir and Favipiravir in the Treatment of Covid-19 Publisher Pubmed



Shahrbaf MA1 ; Tabary M2 ; Khaheshi I1
Authors

Source: Cardiovascular and Hematological Disorders - Drug Targets Published:2021


Abstract

After the outbreak of COVID-19, many novel drugs have been introduced to improve pa-tients’ conditions. Remdesivir and Favipiravir are among the most common drugs used against SARS-CoV-2. Although promising, cardiovascular side effects of these drugs should be considered by physicians and nurses. In this study, we searched databases for assessing the cardiovascular side effects of Remdesivir and Favipiravir. It seems that despite the beneficial effects of these drugs, due to the cardiovascular complications of COVID-19 and cardiovascular side effects of these drugs, which can overlap with each other, the use of these drugs can be a challenging issue in the cardiovascular practice. © 2021 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
2. Investigation of Effective Drugs in the Treatment of Patients With Covid-19, Journal of Iranian Medical Council (2023)
3. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (2)
Arezoo Ahmadi (2)
Other Related Docs
4. The Efficacy of Remdesivir in Coronavirus Disease 2019 (Covid-19): A Systematic Review, Iranian Journal of Microbiology (2020)
5. Safety and Efficacy of Remdesivir for the Treatment of Covid-19: A Rapid Review of Available Evidence, Health Technology Assessment in Action (2020)
6. How to Overcome Cardiovascular Challenges in Covid-19 Patients: A Guide for Common Practice, Acta Biomedica (2020)
7. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
8. Comparison of the Eight Different Treatment Regimens for the Hospitalized Patients With Covid-19: A Retrospective Cohort Study, Journal of Cellular and Molecular Anesthesia (2021)
9. Interferon Therapy in Patients With Sars, Mers, and Covid-19: A Systematic Review and Meta-Analysis of Clinical Studies, European Journal of Pharmacology (2021)
10. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
11. Safety and Effectiveness of Favipiravir for Novel Coronavirus (Covid-19): A Rapid Review of Available Evidence, Health Technology Assessment in Action (2020)
12. Sofosbuvir and Daclatasvir for the Treatment of Covid-19 Outpatients: A Double-Blind, Randomized Controlled Trial, Journal of Antimicrobial Chemotherapy (2021)
13. Remdesivir Administration in Covid-19 Patients With Renal Impairment: A Systematic Review, American Journal of Therapeutics (2022)
14. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
15. Evaluation of Clinical Outcomes in Covid-19 Patients Receiving Remdesivir in Outpatient Setting, Iranian Journal of Pharmaceutical Sciences (2024)
16. Remdesivir-Associated Significant Bradycardia: A Report of Three Cases, Journal of Tehran University Heart Center (2021)
17. Remdesivir: Treatment of Covid-19 in Special Populations, Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
18. The Drug Effectiveness and Side Effects of Remdesivir in Neonatal Covid-19: A Case Series Study, Archives of Pediatric Infectious Diseases (2024)
19. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
20. Effects of Remdesivir on In-Hospital and Late Outcomes of Patients With Confirmed or Clinically Suspected Covid-19: A Propensity Score-Matched Study, Acta Medica Iranica (2022)